SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-322379
Filing Date
2020-12-21
Accepted
2020-12-21 08:06:28
Documents
4
Period of Report
2020-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d848298d8k.htm 8-K 27999
2 EX-10.1 d848298dex101.htm EX-10.1 30934
3 EX-99.1 d848298dex991.htm EX-99.1 12816
4 GRAPHIC g848298equillium.jpg GRAPHIC 15083
  Complete submission text file 0001193125-20-322379.txt   94024
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 201402437
SIC: 2834 Pharmaceutical Preparations